Pioglitazone reduces monocyte activation in type 2 diabetes.
about
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusAdjunctive therapies and immunomodulating agents for severe influenza.Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.How to approach and treat viral infections in ICU patientsPioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.Immunomodulatory therapy for severe influenza.Reconfiguration of NKT Cell Subset Compartment Is Associated with Plaque Development in Patients with Carotid Artery Stenosis.9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4.
P2860
Q24235718-CE48247A-8FFB-4D9B-8A2C-78DB86719D1DQ24240522-6ED29846-2127-4FF1-9379-E27741BBE8D4Q30355446-4FB81455-DC49-4543-8FF7-367F8F07A97CQ30392708-B588A1E0-7C06-437F-9D2B-FB2EFF602D0DQ34894660-C06FDAB4-4071-4354-B05C-58CD9B3BFFE9Q37281187-B8A94E5F-2F86-41E1-834D-5595F2F87DC5Q37910249-45B01024-4EBF-44B8-84C5-B223B164855DQ39252182-19024894-F69A-408C-98C3-812370F6EC45Q55135310-E77A16DF-9CCE-44C9-B465-9D7792590680
P2860
Pioglitazone reduces monocyte activation in type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Pioglitazone reduces monocyte activation in type 2 diabetes.
@en
Pioglitazone reduces monocyte activation in type 2 diabetes.
@nl
type
label
Pioglitazone reduces monocyte activation in type 2 diabetes.
@en
Pioglitazone reduces monocyte activation in type 2 diabetes.
@nl
prefLabel
Pioglitazone reduces monocyte activation in type 2 diabetes.
@en
Pioglitazone reduces monocyte activation in type 2 diabetes.
@nl
P2093
P50
P1433
P1476
Pioglitazone reduces monocyte activation in type 2 diabetes
@en
P2093
Dario Pitocco
Enrico Di Stasio
Filippo Crea
Francesco Zaccardi
Giovanni Ghirlanda
Simona Giubilato
P2888
P356
10.1007/S00592-008-0058-3
P577
2008-09-27T00:00:00Z